Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

22.25
Delayed Data
As of Nov 16
 -0.37 / -1.64%
Today’s Change
12.40
Today|||52-Week Range
25.96
+17.41%
Year-to-Date

Today’s Trading

Previous close22.62
Today’s open22.49
Day’s range22.12 - 22.83
Volume9,454,689
Average volume (3 months)11,472,727
Market cap$23.0B
Data as of 4:00pm ET, 11/16/2018

Growth & Valuation

Earnings growth (last year)-23,426.50%
Earnings growth (this year)-27.03%
Earnings growth (next 5 years)-1.65%
Revenue growth (last year)+2.60%
P/E ratioNM
Price/Sales0.85
Price/Book1.68

Competitors

 Today’s
change
Today’s
% change
BGNEBeiGene Ltd+0.02+0.02%
AKRXAkorn Inc-0.10-1.44%
OASMOasmia Pharmaceutica...-0.17-3.37%
Data as of 4:00pm ET, 11/16/2018

Financials

Next reporting dateFebruary 7, 2019
EPS forecast (this quarter)$0.55
Annual revenue (last year)$22.5B
Annual profit (last year)-$16.4B
Net profit margin-72.66%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Kåre Schultz
Executive Vice President-
Global Operations
Carlo de Notaristefani
Corporate headquarters
Petach Tikva, Hamerkaz

Forecasts